Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group - Wikidata - awgldk - TriplyDB

Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group

Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group

http://www.wikidata.org/entity/Q37120672

about

Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation in vitro and in vivo Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors.Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma.RESEARCH ADVANCES IN NEUROBLASTOMA IMMUNOTHERAPY.Optimizing drug development of anti-cancer drugs in children using modelling and simulation.Optimizing drug therapy in pediatric SCT: focus on pharmacokinetics.Topotecan and cyclophosphamide in adults with relapsed sarcoma.Pharmacokinetics of cyclophosphamide after oral and intravenous administration to dogs with lymphoma.Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation.Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human Liver.

P2860

Q28535586-F01A4160-69EB-4686-B42B-9CDA117C463E Q33396263-4613AD75-DBBA-440F-B883-10644588CE9D Q33998443-85894305-CEE5-4D44-884B-C0F55E2170D6 Q35647150-3ADF8A2D-73AD-44E0-B2E5-535DF6122630 Q36511158-21E35B4C-F27B-43E3-A52C-494BB0BD1BE9 Q36652629-804524A7-EE04-4711-AD98-52C74CC048F6 Q36776358-EC2A7DEA-3716-4F55-A4C9-6246EB5A997E Q36987975-AE5420E3-91B7-4466-857C-AEE50C82A6B5 Q38262916-C3484343-857D-4A02-9625-66D8D60708AB Q40278945-FA48C406-5629-487B-AD1E-70E0E41AF6D3 Q43150200-ED274556-E669-4DE7-ADFF-1265B5E28343 Q44028238-93366C4A-B974-40DA-90E2-9841297E142E Q50948139-237295BA-AC78-40CC-A240-DB6A0A919602

P2860

Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group

http://www.wikidata.org/entity/Q37120672

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Population pharmacokinetics of ...... the Children's Oncology Group

@en

Population pharmacokinetics of ...... the Children's Oncology Group.

@nl

type

label

Population pharmacokinetics of ...... the Children's Oncology Group

@en

Population pharmacokinetics of ...... the Children's Oncology Group.

@nl

prefLabel

Population pharmacokinetics of ...... the Children's Oncology Group

@en

Population pharmacokinetics of ...... the Children's Oncology Group.

@nl

P1433

Q37120672-CCDC1517-3322-4932-9AF7-CC7E2C309450

P1476

Q37120672-94FF38E2-1804-4F5A-81E0-3C9383E9AEF3

P2093

Q37120672-543478CC-55E5-400F-A115-06308CDC6023

Q37120672-54F7B958-FCB6-4973-9A57-56FC4DA217AE

Q37120672-56A99D34-4C18-482C-BCA1-2C830B5CFB1C

Q37120672-BD25B514-6384-4955-AEF9-AB2D3415B0BC

Q37120672-EF6E25AD-011B-4A1C-96A0-A71DE952A642

P2860

Q37120672-0887E7C1-1CAA-4C1B-9878-45ABBCEA1F25

Q37120672-136A6B92-3BCF-4B10-9602-52603C0CCAC2

Q37120672-1A09661D-314A-474A-B337-985055203F59

Q37120672-1C01D5BB-050A-4D9E-85A5-E3EE13ED616C

Q37120672-1FD14C4C-49FC-4A34-924A-884FE208E05F

Q37120672-2B25D9F8-A810-45D4-99B9-1D526973C415

Q37120672-37050E30-F6CF-49C9-AA79-8185247E49D8

Q37120672-3CE7914E-702A-4E2A-9AE6-A419FA5D9C07

Q37120672-40DF51EE-4984-46E7-A0AA-0C3E3050C4ED

Q37120672-5504DA54-B2F9-4BC1-ADB6-7C4CAF9AB4CD

P304

Q37120672-177291C1-ED99-43BE-B584-F3BE997409AB

P31

Q37120672-84635BC7-694B-43DC-94A0-9408F3E2B420

P356

Q37120672-CB989CD1-72E6-44E7-A4B7-394DD9381B36

P433

Q37120672-3657078C-B566-4F83-852F-8D241640806D

P478

Q37120672-FFA17CAE-FA55-4541-B2AF-0A2FCCA38E4B

P50

Q37120672-17DB1C4E-46D1-43B5-93E1-ADA371E4AF8C

P577

Q37120672-4583DCE0-CAD8-4348-A3F0-13F5A9C29311

P5875

Q37120672-18F05836-9645-415A-BA4E-41037C284D8B

P698

Q37120672-0CF8AC67-5265-4C99-9E56-3AF2D0A919E2

P932

Q37120672-F970F8D8-1E1E-4F6B-8279-BC1B0BD16708

P356

0091270008325928

P1433

The Journal of Clinical Pharmacology

P1476

Population pharmacokinetics of ...... the Children's Oncology Group

@en

P2093

Celeste Oglesby

http://www.w3.org/2001/XMLSchema#string

David H Salinger

http://www.w3.org/2001/XMLSchema#string

David K Blough

http://www.w3.org/2001/XMLSchema#string

Julie R Park

http://www.w3.org/2001/XMLSchema#string

Paolo Vicini

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response

Analysis of cyclophosphamide and five metabolites from human plasma using liquid chromatography-mass spectrometry and gas chromatography-nitrogen-phosphorus detection.

Body surface area in normal-weight, overweight, and obese adults. A comparison study.

Cyclophosphamide and related anticancer drugs.

Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.

The importance of pharmacokinetic limited sampling models for childhood cancer drug development.

A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients.

Clinical pharmacokinetics of cyclophosphamide.

High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.

P304

88-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270008325928

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Jeannine S. McCune

P577

2008-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23388733

http://www.w3.org/2001/XMLSchema#string

P698

18927240

http://www.w3.org/2001/XMLSchema#string

P932

2652687

http://www.w3.org/2001/XMLSchema#string